Table 2.
Clinical outcomes after chemotherapy | |||
---|---|---|---|
|
|||
Variables | SD+PR | PD | P |
G | 5 (11.36%) | 4 (9.10%) | |
G+FU/G+P | 4 (9.10%)/16 (36.37%) | 1 (2.27%)/14 (31.82%) | 0.932 |
RRM1 | |||
Negative | 16 (36.37%) | 6 (13.64%) | |
Positive | 9 (20.45%) | 13 (29.55%) | 0.033 |
hENT-1 | |||
Negative | 7 (15.91%) | 11 (25.00%) | |
Positive | 18 (40.91%) | 8 (18.18%) | 0.046 |
G, gemcitabine; FU, 5-fluorouracil; P, cis-platinum; PR, partial response; SD, stable disease; PD, progression disease.